organic compounds
4-(Methylsulfonyl)piperazin-1-ium chloride
aX-ray Crystallography Unit, School of Physics, Universiti Sains Malaysia, 11800 USM, Penang, Malaysia, bDepartment of Studies in Chemistry, University of Mysore, Manasagangotri, Mysore 570 006, India, and cDepartment of Studies in Chemistry, Mangalore University, Mangalagangotri 574 199, India
*Correspondence e-mail: hkfun@usm.my
In the title molecular salt, C5H13N2O2S+·Cl−, the complete cation is generated by crystallographic mirror symmetry, with both N atoms, the S atom and one C atom lying on the reflecting plane. The chloride ion also lies on the mirror plane. The piperazinium ring adopts a chair conformation and the N—S bond adopts an equatorial orientation. In the the component ions are linked into a three-dimensional framework by intermolecular N—H⋯Cl and C—H⋯Cl hydrogen bonds.
Related literature
For medicinal background to piperazine derivatives, see: Dinsmore & Beshore (2002); Berkheij et al. (2005); Humle & Cherrier (1999). For related structures, see: Bart et al. (1978); Girisha et al. (2008); Homrighausen & Krause Bauer (2002); Jin et al. (2007); Kubo et al. (2007); Parkin et al. (2004); Shen et al. (2006), Wang et al. (2006). For ring conformations, see: Cremer & Pople (1975). For the stability of the temperature controller used for the data collection, see: Cosier & Glazer (1986).
Experimental
Crystal data
|
Refinement
|
Data collection: APEX2 (Bruker, 2009); cell SAINT (Bruker, 2009); data reduction: SAINT program(s) used to solve structure: SHELXTL (Sheldrick, 2008); program(s) used to refine structure: SHELXTL; molecular graphics: SHELXTL; software used to prepare material for publication: SHELXTL and PLATON (Spek, 2009).
Supporting information
https://doi.org/10.1107/S1600536810001224/hb5306sup1.cif
contains datablocks global, I. DOI:Structure factors: contains datablock I. DOI: https://doi.org/10.1107/S1600536810001224/hb5306Isup2.hkl
The title compound was obtained as a gift sample from R. L. Fine Chem., Bangalore, India. The compound was used without further purification. Colourless plates of (I) were obtained from slow evaporation of a methanol solution (m.p.: 489–492 K).
Piperazines are among the most important building blocks in today's drug discovery. The piperazine nucleus is capable of binding to multiple receptors with high affinity and therefore piperazine has been classified as a privileged structure (Dinsmore & Beshore, 2002). They are found in biologically active compounds across a number of different therapeutic areas (Berkheij et al., 2005) such as antifungal, antibacterial, antimalarial, antipsychotic, antidepressant and antitumour activity against colon, prostate, breast, lung and leukemia tumors (Humle & Cherrier, 1999). The piperazines are a broad class of chemical compounds, many with important pharmacological properties, which contain a core piperazine
1-(Methylsulfonyl)piperazine is an important intermediate in synthetic organic chemistry, mainly used as a pharmaceutical intermediate.The crystal structures of trans-2,5-dimethylpiperazine dihydrochloride (Bart et al., 1978), 1-(3-chlorophenyl)-4-(3-chloropropyl)piperazinium chloride (Homrighausen & Krause Bauer, 2002), piperazine (Parkin et al., 2004), 2,2'-(piperazine-1,4-diium-1,4-diyl)diacetate dehydrate (Shen et al., 2006), 1,4-bis(chloroacetyl)piperazine (Wang et al., 2006), 1,4-bis(1-naphthylmethyl) piperazine (Kubo et al., 2007), 1,4-bis(4-chlorobenzo-yl)piperazine (Jin et al., 2007) and 1-benzhydryl-4-(4-chlorophenylsulfonyl) piperazine (Girisha et al., 2008) have been reported. In view of the importance of the title compound, this paper reports its crystal structure.
The θ = 179.90 (7)°, φ = 180 (7)° (Cremer & Pople, 1975). In the (Fig. 2), the molecules are linked into a three-dimensional framework by intermolecular hydrogen bonds (Table 1).
of the title compound contains one-half of a cation and half of a cloride anion (Fig. 1). The Cl1, S1, N1, N2, and C3 atoms are lying on a mirror plane. The piperazinium ring adopts a chair conformation with puckering amplitude Q = 0.5680 (7) Å,For medicinal background to piperazine derivatives, see: Dinsmore & Beshore (2002); Berkheij et al. (2005); Humle & Cherrier (1999). For related structures, see: Bart et al. (1978); Girisha et al. (2008); Homrighausen & Krause Bauer (2002); Jin et al. (2007); Kubo et al. (2007); Parkin et al. (2004); Shen et al. (2006), Wang et al. (2006). For ring conformations, see: Cremer & Pople (1975). For stability of the temperature controller used for the data collection, see: Cosier & Glazer (1986).
Data collection: APEX2 (Bruker, 2009); cell
SAINT (Bruker, 2009); data reduction: SAINT (Bruker, 2009); program(s) used to solve structure: SHELXTL (Sheldrick, 2008); program(s) used to refine structure: SHELXTL (Sheldrick, 2008); molecular graphics: SHELXTL (Sheldrick, 2008); software used to prepare material for publication: SHELXTL (Sheldrick, 2008) and PLATON (Spek, 2009).C5H13N2O2S+·Cl− | F(000) = 212 |
Mr = 200.68 | Dx = 1.548 Mg m−3 |
Monoclinic, P21/m | Mo Kα radiation, λ = 0.71073 Å |
Hall symbol: -P 2yb | Cell parameters from 4890 reflections |
a = 6.0231 (1) Å | θ = 3.4–40.1° |
b = 9.1097 (2) Å | µ = 0.64 mm−1 |
c = 7.9852 (2) Å | T = 100 K |
β = 100.700 (1)° | Plate, colourless |
V = 430.52 (2) Å3 | 0.36 × 0.32 × 0.05 mm |
Z = 2 |
Bruker APEX Duo CCD diffractometer | 2790 independent reflections |
Radiation source: fine-focus sealed tube | 2419 reflections with I > 2σ(I) |
Graphite monochromator | Rint = 0.022 |
φ and ω scans | θmax = 40.1°, θmin = 2.6° |
Absorption correction: multi-scan (SADABS; Bruker, 2009) | h = −10→10 |
Tmin = 0.801, Tmax = 0.968 | k = −14→16 |
10626 measured reflections | l = −14→14 |
Refinement on F2 | Primary atom site location: structure-invariant direct methods |
Least-squares matrix: full | Secondary atom site location: difference Fourier map |
R[F2 > 2σ(F2)] = 0.023 | Hydrogen site location: inferred from neighbouring sites |
wR(F2) = 0.072 | H atoms treated by a mixture of independent and constrained refinement |
S = 1.10 | w = 1/[σ2(Fo2) + (0.0335P)2 + 0.0922P] where P = (Fo2 + 2Fc2)/3 |
2790 reflections | (Δ/σ)max = 0.001 |
87 parameters | Δρmax = 0.49 e Å−3 |
0 restraints | Δρmin = −0.40 e Å−3 |
C5H13N2O2S+·Cl− | V = 430.52 (2) Å3 |
Mr = 200.68 | Z = 2 |
Monoclinic, P21/m | Mo Kα radiation |
a = 6.0231 (1) Å | µ = 0.64 mm−1 |
b = 9.1097 (2) Å | T = 100 K |
c = 7.9852 (2) Å | 0.36 × 0.32 × 0.05 mm |
β = 100.700 (1)° |
Bruker APEX Duo CCD diffractometer | 2790 independent reflections |
Absorption correction: multi-scan (SADABS; Bruker, 2009) | 2419 reflections with I > 2σ(I) |
Tmin = 0.801, Tmax = 0.968 | Rint = 0.022 |
10626 measured reflections |
R[F2 > 2σ(F2)] = 0.023 | 0 restraints |
wR(F2) = 0.072 | H atoms treated by a mixture of independent and constrained refinement |
S = 1.10 | Δρmax = 0.49 e Å−3 |
2790 reflections | Δρmin = −0.40 e Å−3 |
87 parameters |
Experimental. The crystal was placed in the cold stream of an Oxford Cyrosystems Cobra open-flow nitrogen cryostat (Cosier & Glazer, 1986) operating at 100.0 (1) K. |
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes. |
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger. |
x | y | z | Uiso*/Ueq | ||
Cl1 | 0.30674 (3) | 0.2500 | 0.93448 (3) | 0.01195 (5) | |
S1 | 0.69091 (3) | 0.2500 | 0.56598 (2) | 0.00951 (5) | |
N1 | 0.82854 (12) | 0.2500 | 0.03611 (9) | 0.01007 (11) | |
N2 | 0.79320 (12) | 0.2500 | 0.38830 (9) | 0.00974 (11) | |
O1 | 0.75935 (9) | 0.11396 (6) | 0.65235 (6) | 0.01498 (9) | |
C1 | 0.87784 (10) | 0.11522 (7) | 0.14202 (8) | 0.01165 (9) | |
C2 | 0.74465 (10) | 0.11465 (7) | 0.28537 (8) | 0.01168 (9) | |
C3 | 0.39411 (15) | 0.2500 | 0.50705 (12) | 0.01332 (13) | |
H1A | 0.8351 (18) | 0.0315 (13) | 0.0719 (14) | 0.012 (2)* | |
H1B | 1.040 (2) | 0.1186 (13) | 0.1845 (16) | 0.016 (3)* | |
H2A | 0.583 (2) | 0.1017 (14) | 0.2371 (15) | 0.018 (3)* | |
H2B | 0.789 (2) | 0.0335 (16) | 0.3554 (17) | 0.027 (3)* | |
H3A | 0.331 (3) | 0.2500 | 0.606 (2) | 0.019 (4)* | |
H3B | 0.350 (2) | 0.3381 (15) | 0.4460 (16) | 0.025 (3)* | |
H1N1 | 0.914 (3) | 0.2500 | −0.048 (2) | 0.019 (4)* | |
H2N1 | 0.677 (3) | 0.2500 | −0.017 (2) | 0.021 (4)* |
U11 | U22 | U33 | U12 | U13 | U23 | |
Cl1 | 0.00886 (7) | 0.01261 (8) | 0.01485 (9) | 0.000 | 0.00346 (6) | 0.000 |
S1 | 0.01110 (8) | 0.01033 (8) | 0.00696 (8) | 0.000 | 0.00128 (6) | 0.000 |
N1 | 0.0098 (2) | 0.0115 (3) | 0.0095 (3) | 0.000 | 0.00316 (19) | 0.000 |
N2 | 0.0126 (2) | 0.0084 (2) | 0.0087 (2) | 0.000 | 0.0032 (2) | 0.000 |
O1 | 0.01874 (19) | 0.01499 (19) | 0.01109 (18) | 0.00356 (16) | 0.00245 (15) | 0.00480 (15) |
C1 | 0.0148 (2) | 0.00900 (19) | 0.0122 (2) | 0.00097 (17) | 0.00547 (17) | −0.00041 (17) |
C2 | 0.0162 (2) | 0.0083 (2) | 0.0117 (2) | −0.00109 (16) | 0.00571 (17) | −0.00060 (16) |
C3 | 0.0115 (3) | 0.0166 (3) | 0.0121 (3) | 0.000 | 0.0027 (2) | 0.000 |
S1—O1i | 1.4408 (5) | N2—C2i | 1.4806 (7) |
S1—O1 | 1.4408 (5) | C1—C2 | 1.5148 (8) |
S1—N2 | 1.6484 (7) | C1—H1A | 0.953 (11) |
S1—C3 | 1.7621 (9) | C1—H1B | 0.976 (12) |
N1—C1 | 1.4892 (7) | C2—H2A | 0.983 (13) |
N1—C1i | 1.4892 (7) | C2—H2B | 0.935 (14) |
N1—H1N1 | 0.920 (17) | C3—H3A | 0.941 (18) |
N1—H2N1 | 0.933 (19) | C3—H3B | 0.951 (14) |
N2—C2 | 1.4806 (7) | ||
O1i—S1—O1 | 118.67 (4) | N1—C1—C2 | 110.75 (5) |
O1i—S1—N2 | 107.01 (2) | N1—C1—H1A | 108.8 (7) |
O1—S1—N2 | 107.01 (2) | C2—C1—H1A | 108.5 (6) |
O1i—S1—C3 | 108.28 (3) | N1—C1—H1B | 104.6 (7) |
O1—S1—C3 | 108.29 (3) | C2—C1—H1B | 112.1 (7) |
N2—S1—C3 | 107.03 (4) | H1A—C1—H1B | 112.0 (9) |
C1—N1—C1i | 111.07 (7) | N2—C2—C1 | 109.81 (5) |
C1—N1—H1N1 | 109.7 (5) | N2—C2—H2A | 113.4 (7) |
C1i—N1—H1N1 | 109.7 (5) | C1—C2—H2A | 109.1 (7) |
C1—N1—H2N1 | 109.5 (5) | N2—C2—H2B | 108.7 (8) |
C1i—N1—H2N1 | 109.5 (5) | C1—C2—H2B | 108.7 (7) |
H1N1—N1—H2N1 | 107.3 (15) | H2A—C2—H2B | 107.1 (10) |
C2—N2—C2i | 112.77 (7) | S1—C3—H3A | 108.9 (11) |
C2—N2—S1 | 114.27 (4) | S1—C3—H3B | 108.1 (8) |
C2i—N2—S1 | 114.27 (4) | H3A—C3—H3B | 108.3 (9) |
O1i—S1—N2—C2 | 178.10 (5) | C3—S1—N2—C2i | 66.00 (5) |
O1—S1—N2—C2 | 49.91 (6) | C1i—N1—C1—C2 | 56.95 (8) |
C3—S1—N2—C2 | −65.99 (5) | C2i—N2—C2—C1 | 56.73 (8) |
O1i—S1—N2—C2i | −49.91 (6) | S1—N2—C2—C1 | −170.56 (4) |
O1—S1—N2—C2i | −178.10 (5) | N1—C1—C2—N2 | −55.89 (7) |
Symmetry code: (i) x, −y+1/2, z. |
D—H···A | D—H | H···A | D···A | D—H···A |
N1—H1N1···Cl1ii | 0.92 (2) | 2.40 (2) | 3.1341 (8) | 137 (1) |
N1—H2N1···Cl1iii | 0.93 (2) | 2.19 (2) | 3.0966 (8) | 164 (1) |
C1—H1A···Cl1iv | 0.953 (12) | 2.700 (12) | 3.5251 (6) | 145.2 (9) |
C3—H3A···Cl1 | 0.94 (2) | 2.65 (2) | 3.5487 (10) | 160 (2) |
Symmetry codes: (ii) x+1, y, z−1; (iii) x, y, z−1; (iv) −x+1, y−1/2, −z+1. |
Experimental details
Crystal data | |
Chemical formula | C5H13N2O2S+·Cl− |
Mr | 200.68 |
Crystal system, space group | Monoclinic, P21/m |
Temperature (K) | 100 |
a, b, c (Å) | 6.0231 (1), 9.1097 (2), 7.9852 (2) |
β (°) | 100.700 (1) |
V (Å3) | 430.52 (2) |
Z | 2 |
Radiation type | Mo Kα |
µ (mm−1) | 0.64 |
Crystal size (mm) | 0.36 × 0.32 × 0.05 |
Data collection | |
Diffractometer | Bruker APEX Duo CCD |
Absorption correction | Multi-scan (SADABS; Bruker, 2009) |
Tmin, Tmax | 0.801, 0.968 |
No. of measured, independent and observed [I > 2σ(I)] reflections | 10626, 2790, 2419 |
Rint | 0.022 |
(sin θ/λ)max (Å−1) | 0.906 |
Refinement | |
R[F2 > 2σ(F2)], wR(F2), S | 0.023, 0.072, 1.10 |
No. of reflections | 2790 |
No. of parameters | 87 |
H-atom treatment | H atoms treated by a mixture of independent and constrained refinement |
Δρmax, Δρmin (e Å−3) | 0.49, −0.40 |
Computer programs: APEX2 (Bruker, 2009), SAINT (Bruker, 2009), SHELXTL (Sheldrick, 2008) and PLATON (Spek, 2009).
D—H···A | D—H | H···A | D···A | D—H···A |
N1—H1N1···Cl1i | 0.919 (17) | 2.395 (18) | 3.1341 (8) | 137.4 (14) |
N1—H2N1···Cl1ii | 0.932 (18) | 2.192 (18) | 3.0966 (8) | 163.5 (14) |
C1—H1A···Cl1iii | 0.953 (12) | 2.700 (12) | 3.5251 (6) | 145.2 (9) |
C3—H3A···Cl1 | 0.938 (17) | 2.654 (16) | 3.5487 (10) | 159.6 (15) |
Symmetry codes: (i) x+1, y, z−1; (ii) x, y, z−1; (iii) −x+1, y−1/2, −z+1. |
Acknowledgements
HKF thanks Universiti Sains Malaysia (USM) for the Research University Golden Goose Grant (No. 1001/PFIZIK/811012). CSY thanks USM for the award of a USM Fellowship. CSC thanks University of Mysore for research facilities.
References
Bart, J. C. J., Bassi, I. W. & Scordamaglia, R. (1978). Acta Cryst. B34, 2760–2764. CSD CrossRef CAS IUCr Journals Web of Science Google Scholar
Berkheij, M., van der Sluis, L., Sewing, C., den Boer, D. J., Terpstra, J. W., Heimstra, H., Bakker, W. I. I., van den Hoogen Band, A. & van Maarseveen, J. H. (2005). Tetrahedron, 46, 2369–2371. CrossRef CAS Google Scholar
Bruker (2009). APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA. Google Scholar
Cosier, J. & Glazer, A. M. (1986). J. Appl. Cryst. 19, 105–107. CrossRef CAS Web of Science IUCr Journals Google Scholar
Cremer, D. & Pople, J. A. (1975). J. Am. Chem. Soc. 97, 1354–1358. CrossRef CAS Web of Science Google Scholar
Dinsmore, C. J. & Beshore, D. C. (2002). Tetrahedron, 58, 3297–3312. Web of Science CrossRef CAS Google Scholar
Girisha, H. R., Naveen, S., Vinaya, K., Sridhar, M. A., Shashidhara Prasad, J. & Rangappa, K. S. (2008). Acta Cryst. E64, o358. Web of Science CSD CrossRef IUCr Journals Google Scholar
Homrighausen, C. L. & Krause Bauer, J. A. (2002). Acta Cryst. E58, o1395–o1396. Web of Science CSD CrossRef IUCr Journals Google Scholar
Humle, C. & Cherrier, M. P. (1999). Tetrahedron Lett. 40, 5295–5299. Google Scholar
Jin, H.-M., Li, P.-F., Li, C.-Y. & Liu, B. (2007). Acta Cryst. E63, o3689. Web of Science CSD CrossRef IUCr Journals Google Scholar
Kubo, K., Yamamoto, E., Hayakawa, A., Sakurai, T. & Mori, A. (2007). Acta Cryst. E63, o1347–o1348. Web of Science CSD CrossRef IUCr Journals Google Scholar
Parkin, A., Oswald, I. D. H. & Parsons, S. (2004). Acta Cryst. B60, 219–227. Web of Science CSD CrossRef CAS IUCr Journals Google Scholar
Sheldrick, G. M. (2008). Acta Cryst. A64, 112–122. Web of Science CrossRef CAS IUCr Journals Google Scholar
Shen, L., Wang, F.-W., Cheng, A.-B. & Yang, S. (2006). Acta Cryst. E62, o2242–o2244. Web of Science CSD CrossRef IUCr Journals Google Scholar
Spek, A. L. (2009). Acta Cryst. D65, 148–155. Web of Science CrossRef CAS IUCr Journals Google Scholar
Wang, J., Zeng, T., Li, M.-L., Duan, E.-H. & Li, J.-S. (2006). Acta Cryst. E62, o2912–o2913. Web of Science CSD CrossRef IUCr Journals Google Scholar
This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.
Piperazines are among the most important building blocks in today's drug discovery. The piperazine nucleus is capable of binding to multiple receptors with high affinity and therefore piperazine has been classified as a privileged structure (Dinsmore & Beshore, 2002). They are found in biologically active compounds across a number of different therapeutic areas (Berkheij et al., 2005) such as antifungal, antibacterial, antimalarial, antipsychotic, antidepressant and antitumour activity against colon, prostate, breast, lung and leukemia tumors (Humle & Cherrier, 1999). The piperazines are a broad class of chemical compounds, many with important pharmacological properties, which contain a core piperazine functional group. 1-(Methylsulfonyl)piperazine is an important intermediate in synthetic organic chemistry, mainly used as a pharmaceutical intermediate.
The crystal structures of trans-2,5-dimethylpiperazine dihydrochloride (Bart et al., 1978), 1-(3-chlorophenyl)-4-(3-chloropropyl)piperazinium chloride (Homrighausen & Krause Bauer, 2002), piperazine (Parkin et al., 2004), 2,2'-(piperazine-1,4-diium-1,4-diyl)diacetate dehydrate (Shen et al., 2006), 1,4-bis(chloroacetyl)piperazine (Wang et al., 2006), 1,4-bis(1-naphthylmethyl) piperazine (Kubo et al., 2007), 1,4-bis(4-chlorobenzo-yl)piperazine (Jin et al., 2007) and 1-benzhydryl-4-(4-chlorophenylsulfonyl) piperazine (Girisha et al., 2008) have been reported. In view of the importance of the title compound, this paper reports its crystal structure.
The asymmetric unit of the title compound contains one-half of a cation and half of a cloride anion (Fig. 1). The Cl1, S1, N1, N2, and C3 atoms are lying on a mirror plane. The piperazinium ring adopts a chair conformation with puckering amplitude Q = 0.5680 (7) Å, θ = 179.90 (7)°, φ = 180 (7)° (Cremer & Pople, 1975). In the crystal structure (Fig. 2), the molecules are linked into a three-dimensional framework by intermolecular hydrogen bonds (Table 1).